Healio

Radiofrequency ablation eliminates tumor for most adults with low-risk thyroid cancer

Please provide your email address to receive an email when new articles are posted on . Radiofrequency ablation had a technical efficacy of 96.1% for adults with low-risk thyroid cancer. Tumor ...
Nasdaq

IceCure's ProSense® Featured in 6 Global Studies on Cryoablation of Breast Tumors at the 2024 European Society of Breast Imaging Conference

CAESAREA, Israel, Oct. 7, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that ...
The New England Journal of Medicine

Complete Ablation of the Thyroid Gland in a Case of Chronic Lymphatic Leukemia with Hypermetabolism

From the Medical and Surgical Services and the Department of Pathology, Beth Israel Hospital, Boston, and the Department of Medicine, Harvard Medical School, Boston. Dameshek, William — Associate ...
Seeking Alpha

Two New Publications from the Independent THERMAC Trial Featuring IceCure's ProSense® in Breast Cancer Finds 95% of Patients Satisfied with Thermal Ablation; ProSense ...

Article published in European Journal of Surgical Oncology focused on cosmetic outcomes and patient satisfaction reports 95% of patients were very satisfied or satisfied with thermal ablation Article ...
Business Wire

Pulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) ...
TCTMD

Lower Mortality for AF Patients When Surgical Ablation Added to CABG: Medicare

Concomitant surgical ablation during CABG in patients with atrial fibrillation (AF) is associated with better survival outcomes, according to new Medicare data. Results were best when the dual ...